Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The injection also works to treat other nutritional deficiencies which helps prevent various health problems
Description BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein sequence associated with gastric juice
Every production batch is verified by High-Performance Liquid Chromatography (HPLC), with a Certificate of Analysis (COA) available upon request to support research quality assurance
After a 2 week screening period all eligible participants were randomly assigned to treatment groups receiving either a subcutaneous injection of 2.4 mg of semaglutide, 2.4 mg of cagrilintide, a combination of cagrilintide and semaglutide, a semaglutide placebo, or a cagrilintide placebo [2]
Vigorous agitation introduces foam and can destabilize protein and peptide solutions
